Effects of cigarette smoke, cessation and switching to a candidate modified risk tobacco product on the liver in Apoe -/- mice-a systems toxicology analysis

Inhalation Toxicology

Volumn 28, Issue 5, 2016, Pages 226-240

  Lo Sasso, Giuseppe ^a   Titz, Bjoern ^a   Nury, Catherine ^a   Boué, Stéphanie ^a   Phillips, Blaine ^a   Belcastro, Vincenzo ^a   Schneider, Thomas ^a   Dijon, Sophie ^a   Baumer, Karine ^a   Peric, Daruisz ^a   Dulize, Remi ^a   Elamin, Ashraf ^a   Guedj, Emmanuel ^a   Buettner, Ansgar ^b   Leroy, Patrice ^a   Kleinhans, Samuel ^a   Vuillaume, Gregory ^a   Veljkovic, Emilija ^a   Ivanov, Nikolai V ^a   Martin, Florian ^a   Vanscheeuwijck, Patrick ^a   Peitsch, Manuel C ^a   Hoeng, Julia ^a   more..

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

^b Histovia GmbH   (Germany)

Author keywords

Data integration; inhalation toxicology; lipidomics; modified risk tobacco product; quantitative proteomics; reduced risk product; systems toxicology; transcriptomics

Indexed keywords

CIGARETTE SMOKE; IRON; PROTEOME; TRANSCRIPTOME; APOLIPOPROTEIN E; SMOKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPOSURE; FEMALE; HOMEOSTASIS; LIPID METABOLISM; LIVER; LIVER TOXICITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEOMICS; RISK ASSESSMENT; SMOKING CESSATION; TOBACCO; TOXICOLOGY; TRANSCRIPTOMICS; XENOBIOTIC METABOLISM; ANIMAL; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; RISK; SMOKE; TOXICITY;

ANIMALS; APOLIPOPROTEINS E; FEMALE; LIPID METABOLISM; LIVER; MICE, KNOCKOUT; PROTEOMICS; RISK; SMOKE; SMOKING CESSATION; TOBACCO; TOBACCO PRODUCTS;

EID: 84961914064     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2016.1150368     Document Type: Article

References (93)

1. Abel J, de Ruiter N. (1989). Inhibition of hydroxyl-radical-generated DNA degradation by metallothionein. Toxicol Lett 47: 191-6.
2. Altamirano J, Bataller R. (2010). Cigarette smoking and chronic liver diseases. Gut 2008: 162453
3. Aoshiba K, Nagai A. (2003). Oxidative stress, cell death, and other damage to alveolar epithelial cells induced by cigarette smoke. Tob Induc Dis 1: 219-26.
4. Arosio P, Yokota M, Drysdale JW. (1976). Structural and immunological relationships of isoferritins in normal and malignant cells. Cancer Res 36: 1735-9.
5. Arunachalam G, Sundar IK, Hwang JW, et al. (2010). Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD. J Inflamm (Lond) 7: 34
6. Azzalini L, Ferrer E, Ramalho LN, et al. (2010). Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology 51: 1567-76.
7. Bartsch H, Nair U, Risch A, et al. (2000). Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 9: 3-28.
8. Bonomini F, Rodella L, Moghadasian M, et al. (2013). Apolipoprotein E deficiency and a mouse model of accelerated liver aging. Biogerontology 14: 209-20.
9. Boué S, De León H, Schlage WK, et al. (2013). Cigarette smoke induces molecular responses in respiratory tissues of ApoE-/-mice that are progressively deactivated upon cessation. Toxicology 314: 112-24.
10. Boué S, Tarasov K, Jänis M, et al. (2012). Modulation of atherogenic lipidome by cigarette smoke in apolipoprotein E-deficient mice. Atherosclerosis 225: 328-34.
11. Boveris A, Oshino N, Chance B. (1972). The cellular production of hydrogen peroxide. Biochem J 128: 617-30.
12. Brown KE, Broadhurst KA, Mathahs MM, Weydert J. (2007). Differential expression of stress-inducible proteins in chronic hepatic iron overload. Toxicol Appl Pharmacol 223: 180-6.
13. Chen J, Bardes EE, Aronow BJ, Jegga AG. (2009). ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 37: W305-11.
14. Church DF, Pryor WA. (1985). Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64: 111
15. Craig WY, Palomaki GE, Haddow JE. (1989). Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 298: 784-8.
16. Daly AK, Cholerton S, Armstrong M, Idle JR. (1994). Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ Health Perspect 102: 55-61
17. De León H, Boué S, Peitsch M, Hoeng J. (2013). Modulation of the hepatic lipidome and transcriptome of Apoe-/-mice in response to smoking cessation. J Liver 2: 132.
18. El-Zayadi AR. (2006). Heavy smoking and liver. World J Gastroenterol 12: 6098-101
19. El-Zayadi AR, Selim O, Hamdy H, et al. (2002). Heavy cigarette smoking induces hypoxic polycythemia (erythrocytosis) and hyperuricemia in chronic hepatitis C patients with reversal of clinical symptoms and laboratory parameters with therapeutic phlebotomy. Am J Gastroenterol 97: 1264-5.
20. Ferdinandusse S, Houten SM. (2006). Peroxisomes and bile acid biosynthesis. Biochim Biophys Acta 1763: 1427-40.
21. Gentleman RC, Carey VJ, Bates DM, et al. (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80
22. Gepner AD, Piper ME, Johnson HM, et al. (2011). Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J 161: 145-51.
23. Ghio AJ, Hilborn ED, Stonehuerner JG, et al. (2008). Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect. Am J Respir Crit Care Med 178: 1130-8.
24. Gutteridge JM, Halliwell B. (1989). Iron toxicity and oxygen radicals. Baillieres Clin Haematol 2: 195-256.
25. Hamabe A, Uto H, Imamura Y, et al. (2011). Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. J Gastroenterol 46: 769-78.
26. Hassett C, Robinson KB, Beck NB, Omiecinski CJ. (1994). The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization. Genomics 23: 433-42.
27. Hattula K, Hirschberg D, Kalkkinen N, et al. (2014). Association between the intrinsically disordered protein PEX19 and PEX3. PLoS One 9: e103101
28. Hayes JD, Flanagan JU, Jowsey IR. (2005). Glutathione transferases. Annu Rev Pharmacol Toxicol 45: 51-88.
29. Hayes JD, McLellan LI. (1999). Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 31: 273-300.
30. Hayes JD, Pulford DJ. (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the lsoenzymes to cancer chemoprotection and drug resistance part II. Crit Rev Biochem Mol Biol 30: 521-600.
31. Helen A, Vijayammal P. (1997). Vitamin C supplementation on hepatic oxidative stress induced by cigarette smoke. J Appl Toxicol 17: 289-95.
32. Hentze MW, Muckenthaler MU, Andrews NC. (2004). Balancing acts: molecular control of mammalian iron metabolism. Cell 117: 285-97.
33. Hsu MH, Savas Ü, Griffin KJ, Johnson EF. (2007). Human cytochrome p450 family 4 enzymes: function, genetic variation and regulation. Drug Metab Rev 39: 515-38.
34. Jung HR, Sylvänne T, Koistinen KM, et al. (2011). High throughput quantitative molecular lipidomics. Biochim Biophys Acta 1811: 925-34.
35. Kanehisa M, Goto S, Sato Y, et al. (2014). Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res 42: D199-205.
36. Kogel U, Schlage WK, Martin F, et al. (2014). A 28-day rat inhalation study with an integrated molecular toxicology endpoint demonstrates reduced exposure effects for a prototypic modified risk tobacco product compared with conventional cigarettes. Food Chem Toxicol 68: 204-17.
37. Kojima N, Young CR, Bates GW. (1982). Failure of metallothionein to bind iron or act as an iron mobilizing agent. Biochim Biophys Acta 716: 273-5.
38. Koturbash I, Scherhag A, Sorrentino J, et al. (2011). Epigenetic mechanisms of mouse inter-strain variability in genotoxicity of the environmental toxicant 1, 3-butadiene. Toxicol Sci 122: 448-56
39. Latha M, Vijayammal P, Kurup P. (1988). Effect of exposure of rats to cigarette smoke on the metabolism of lipids. Atherosclerosis 70: 225-31.
40. Lê Cao KA, González I, Déjean S. (2009). integrOmics: an R package to unravel relationships between two omics datasets. Bioinformatics 25: 2855-6.
41. Liberzon A, Subramanian A, Pinchback R, et al. (2011). Molecular signatures database (MSigDB) 3.0. Bioinformatics 27: 1739-40.
42. Lietz M, Berges A, Lebrun S, et al. (2013). Cigarette-smoke-induced atherogenic lipid profiles in plasma and vascular tissue of apolipoprotein E-deficient mice are attenuated by smoking cessation. Atherosclerosis 229: 86-93.
43. Liu Y, Meyer C, Xu C, et al. (2013). Animal models of chronic liver diseases. Am J Physiol Gastrointest Liver Physiol 304: G449-68.
44. Lu Y, Ward SC, Cederbaum AI. (2013). Nicotine enhances ethanol-induced fat accumulation and collagen deposition but not inflammation in mouse liver. Alcohol 47: 353-7.
45. Matsuzono Y, Kinoshita N, Tamura S, et al. (1999). Human PEX19: cDNA cloning by functional complementation, mutation analysis in a patient with Zellweger syndrome, and potential role in peroxisomal membrane assembly. Proc Natl Acad Sci USA 96: 2116-21.
46. McCall MN, Bolstad BM, Irizarry RA. (2010). Frozen robust multiarray analysis (fRMA). Biostatistics 11: 242-53.
47. Messner B, Bernhard D. (2014). Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol 34: 509-15.
48. Moennikes O, Vanscheeuwijck PM, Friedrichs B, et al. (2008). Reduced toxicological activity of cigarette smoke by the addition of ammonia magnesium phosphate to the paper of an electrically heated cigarette: subchronic inhalation toxicology. Inhal Toxicol 20: 647-63.
49. Moon MS, McDevitt E, Zhu J, et al. (2012). Elevated hepatic iron activates NF-E2-related factor 2 (NRF2) regulated pathway in a dietary iron overload mouse model. Toxicol Sci 129: 74-85
50. Mootha VK, Lindgren CM, Eriksson KF, et al. (2003). PGC-1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-73.
51. Nakashima Y, Plump AS, Raines EW, et al. (1994). ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14: 133-40.
52. Oppermann U. (2007). Carbonyl reductases: the complex relationships of mammalian carbonyl-and quinone-reducing enzymes and their role in physiology. Annu Rev Pharmacol Toxicol 47: 293-322.
53. Pavek P, Dvorak Z. (2008). Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr Drug Metab 9: 129-43.
54. Pessione F, Ramond MJ, Njapoum C, et al. (2001). Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 34: 121-5.
55. Phillips B, Veljkovic E, Peck MJ, et al. (2015). A 7-month cigarette smoke inhalation study in C57BL/6 mice demonstrates reduced lung inflammation and emphysema following smoking cessation or aerosol exposure from a prototypic modified risk tobacco product. Food Chem Toxicol 80: 328-45.
56. Phillips B, Veljkovic E, Boué S, et al. (2016). An 8-month systems toxicology inhalation/cessation study in ApoE-/-mice to investigate cardiovascular and respiratory exposure effects of a candidate modified risk tobacco product, THS 2.2, compared with conventional cigarettes. Toxicol Sci 149: 411-32
57. Phillips IR, Dolphin CT, Clair P, et al. (1995). The molecular biology of the flavin-containing monooxygenases of man. Chem Biol Interact 96: 17-32.
58. Rampling MW. (1993) Clotting factors and rheology: mechanisms of damage and intervention. In: Poulter N, Sever P, Thom S., eds. Cardiovascular disease: risk factors and intervention. Oxford: Radcliffe Medical Press, 201-13
59. Ritchie ME, Phipson B, Wu D, et al. (2015). limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43: e47
60. Robinson D, Whitehead T. (1989). Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening. Ann Clin Biochem 26: 393-400.
61. Rodriguez A, Luukkaala T, Fleming RE, et al. (2009). Global transcriptional response to Hfe deficiency and dietary iron overload in mouse liver and duodenum. PLoS One 4: e7212
62. Russell DW. (1992). Cholesterol biosynthesis and metabolism. Cardiovasc Drugs Ther 6: 103-10.
63. Sacksteder KA, Jones JM, South ST, et al. (2000). PEX19 binds multiple peroxisomal membrane proteins, is predominantly cytoplasmic, and is required for peroxisome membrane synthesis. J Cell Biol 148: 931-44.
64. Sauer JM, Hartung T, Leist M, et al. (2015). Systems toxicology: the future of risk assessment. Int J Toxicol 34: 346-8.
65. Schorp MK, Tricker AR, Dempsey R. (2012). Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 1: non-clinical and clinical insights. Regul Toxicol Pharmacol 64: S1-10.
66. Schrader M, Fahimi HD. (2006). Peroxisomes and oxidative stress. Biochim Biophys Acta 1763: 1755-66.
67. Sheedfar F, Biase SD, Koonen D, Vinciguerra M. (2013). Liver diseases and aging: friends or foes? Aging Cell 12: 950-4.
68. Smith CA, Harrison DJ. (1997). Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350: 630-3.
69. Sturla SJ, Boobis AR, FitzGerald RE, et al. (2014). Systems toxicology: from basic research to risk assessment. Chem Res Toxicol 27: 314-29.
70. Subramanian A, Tamayo P, Mootha VK, et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-50.
71. Szklarczyk D, Franceschini A, Wyder S, et al. (2015). STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 43: D447-52.
72. Tao Y, Wu Q, Guo X, et al. (2014). MBD5 regulates iron metabolism via methylation-independent genomic targeting of Fth1 through KAT2A in mice. Br J Haematol 166: 279-91.
73. Terpstra PM, Teredesai A, Vanscheeuwijck PM, et al. (2003). Toxicological evaluation of an electrically heated cigarette. Part 4: subchronic inhalation toxicology. J Appl Toxicol 23: 349-62.
74. Thomas C, Mackey MM, Diaz AA, Cox DP. (2009). Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress: implications for diseases associated with iron accumulation. Redox Rep 14: 102-8.
75. Thornalley PJ, Vašák M. (1985). Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim Biophys Acta 827: 36-44.
76. Titz B, Boué S, Phillips B, et al. (2016). Effects of cigarette smoke, cessation and switching to two heat-not-burn tobacco products on lung lipid metabolism in C57BL/6 and Apoe-/-mice-an integrative systems toxicology analysis. Toxicol Sci 149: 441-57
77. Titz B, Elamin A, Martin F, et al. (2014). Proteomics for systems toxicology. Comput Struct Biotechnol J 11: 73-90.
78. Tsochatzis E, Papatheodoridis GV, Manolakopoulos S, et al. (2009). Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B. Scand J Gastroenterol 44: 752-9.
79. U.S. Department of Health and Human Services. (2010). How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health
80. Van der Valk P, Gille J, Oostra A, et al. (1985). Characterization of an oxygen-tolerant cell line derived from Chinese hamster ovary. Cell Tissue Res 239: 61-8.
81. Väremo L, Nielsen J, Nookaew I. (2013). Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods. Nucleic Acids Res 41: 4378-91.
82. Vizcaíno JA, Deutsch EW, Wang R, et al. (2014). ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol 32: 223-6.
83. Werley MS, Freelin SA, Wrenn SE, et al. (2008). Smoke chemistry, in vitro and in vivo toxicology evaluations of the electrically heated cigarette smoking system series K. Regul Toxicol Pharmacol 52: 122-39.
84. Whitehead T, Robinson D, Allaway S. (1996). The effects of cigarette smoking and alcohol consumption on serum liver enzyme activities: a dose-related study in men. Ann Clin Biochem 33: 530-5.
85. Yeung D. (1976). Relationships between cigarette smoking, oral contraceptives, and plasma vitamins A, E, C, and plasma triglycerides and cholesterol. Am J Clin Nutr 29: 1216-21.
86. Young CJ, Moss J. (1989). Smoke inhalation: diagnosis and treatment. J Clin Anesth 1: 377-86.
87. Yu MW, Hsu FC, Sheen IS, et al. (1997). Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 145: 1039-47.
88. Zein CO, Beatty K, Post AB, et al. (2006). Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: a cross validated retrospective assessment. Hepatology 44: 1564-71.
89. Zein CO, Unalp A, Colvin R, et al. (2011). Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol 54: 753-9.
90. Zevin S, Benowitz NL. (1999). Drug interactions with tobacco smoking. Clin Pharmacokinet 36: 425-38.
91. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. (1992). Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-71.
92. Zhou X, Zhuo X, Xie F, et al. (2010). Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse model. J Pharmacol Exp Ther 332: 578-87.
93. Zuo L, He F, Sergakis GG, et al. (2014). Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments. Am J Physiol Lung Cell Mol Physiol 307: L205-18.